Objective: To systematically review and analyze studies on specific health guidance in the literature up to now in order to determine its effectiveness as well the degree of improvement resulting from it.
Methods: We conducted a search of the literature using Japan Medical Abstracts Society and PubMed data for studies on specific health guidance from April 2008 to September 2014. From the studies selected, we extracted changes in laboratory values that would be stratification criteria for specific health examinations (SHE) and performed a meta-analysis of the data using weighted mean differences.
Results: Based on the inclusion and exclusion criteria, 7 studies were selected. According to the meta-analysis, differences in changes between the control group and support groups were as below. As compared to the control group, there were significant improvements in the active support group regarding weighted mean changes for the following (95% CI in parenthesis): body weight (kg), -1.31 (-1.67, -0.94); BMI (kg/m
2), -0.45 (-0.57, -0.33); abdominal circumference (cm), -1.49 (-2.02, -0.95); systolic blood pressure (mm Hg), -80 (-1.46, -0.13); triglycerides (mg/dL), -7.47 (-13.45, -1.49); HDL cholesterol (mg/dL), 0.88 (0.53, 1.23); fasting blood glucose (mg/dL), -1.72 (-2.84, -0.61); HbA1c (%) -0.06 (-0.10, -0.03). Compared to the control group, there were significant improvements in the support group with motivation regarding weighted mean changes for the following (95% CI in parenthesis): body weight, -1.01 (-1.30, -0.73); BMI, -0.40 (-0.55, -0.26); abdominal circumference, -1.15 (-1.65, -0.64); triglycerides, -6.95 (-11.74, -2.17); HDL cholesterol 0.71 (0.04, 1.37). Versus the control group, there were significant improvements in the following for all support groups together regarding changes (95% CI in parenthesis): body weight, -1.10 (-1.29, -0.92); BMI, -0.42 (-0.49, -0.35); abdominal circumference, -1.29 (-1.62, -0.96); systolic blood pressure, 0.67 (-1.26, -0.07); diastolic blood pressure, -0.45 (-0.88, -0.01); triglycerides -7.17 (-10.56, -3.79); HDL cholesterol, 0.79 (0.49, 1.09); fasting blood glucose, -1.01 (-1.97, -0.04); HbA1c, -0.07 (-0.11, -0.04).
Conclusion: Specific health guidance is effective in improving laboratory values that would be criteria for stratification in SHE. As heterogeneity is observed in some laboratory values, analysis of subgroups according to subject characteristics and health guidance method is needed.
View full abstract